| No. |
Proposition |
|
For |
Against |
Abstain |
| 1 |
Approval of the extension of the term for preparation by the Companys Board of Directors of the 2025 annual statutory accounts of the Company (prepared in accordance with IFRS). |
|
|
|
|
| 2 |
Adoption of 2025 annual statutory accounts of the Company (prepared in accordance with IFRS). |
|
|
|
|
| 3 |
Discharge of the members of the Board of Directors for their liability towards the Company for their management during the 2025 financial year. |
|
|
|
|
| 4 |
Re-appointment of Arkady Volozh as an executive member of the Board of Directors for a one-year term, to end at the conclusion of the Annual General Meeting to be held in 2027. |
|
|
|
|
| 5 |
Re-appointment of Ophir Nave as an executive member of the Board of Directors for a one-year term, to end at the conclusion of the Annual General Meeting to be held in 2027. |
|
|
|
|
| 6 |
Re-appointment of John Boynton as a non-executive member of the Board of Directors for a one-year term, to end at the conclusion of the Annual General Meeting to be held in 2027. |
|
|
|
|
| 7 |
Re-appointment of Elena Bunina as a non-executive member of the Board of Directors for a one-year term, to end at the conclusion of the Annual General Meeting to be held in 2027. |
|
|
|
|
| 8 |
Re-appointment of Arne Grimme as a non-executive member of the Board of Directors for a one-year term, to end at the conclusion of the Annual General Meeting to be held in 2027. |
|
|
|
|
| 9 |
Re-appointment of Kira Radinsky as a non-executive member of the Board of Directors for a one-year term, to end at the conclusion of the Annual General Meeting to be held in 2027. |
|
|
|
|
| 10 |
Re-appointment of Charles Ryan as a non-executive member of the Board of Directors for a one-year term, to end at the conclusion of the Annual General Meeting to be held in 2027. |
|
|
|
|
| 11 |
Re-appointment of Matthew Weigand as a non-executive member of the Board of Directors for a one-year term, to end at the conclusion of the Annual General Meeting to be held in 2027. |
|
|
|
|
| 12 |
Appointment of the external auditor of the Companys consolidated financial statements and statutory accounts for the 2026 financial year. |
|
|
|
|
| 13 |
General authorization of the Board of Directors to issue and/or grant rights to subscribe for Class A Shares. |
|
|
|
|
| 14 |
General authorization of the Board of Directors to exclude pre-emption rights. |
|
|
|
|
| 15 |
General authorization of the Board of Directors to repurchase Class A Shares. |
|
|
|
|
| 16 |
Cancellation of 2,243,621 Class C shares of the Company. |
|
|
|
|